The Valley Desk

Clinical trial reportRMD openPublished

Low rates of radiographic progression associated with clinical efficacy following up to 2 years of treatment with guselkumab: results from a phase 3, randomised, double-blind, placebo-controlled study of biologic-naïve patients with active psoriatic arthritis

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Drexel University College of Medicine, Johnson & Johnson, with Drexel University linked by the institution reference. Affiliation source

Publication record

Type
Clinical trial report
Venue
RMD open
Published
Subject terms
Humans; Arthritis, Psoriatic; Biological Products; Treatment Outcome; Adult; Antibodies, Monoclonal, Humanized; Autoimmune diseases; Arthritis, psoriatic; Biological Therapy
PubMed ID
36828643
PubMed Central ID
PMC9972414
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal